Dr. Rozhin Penjweini
at University of Pennsylvania
SPIE Involvement:
Author
Publications (18)

SPIE Journal Paper | March 31, 2017
JBO Vol. 22 Issue 04
KEYWORDS: Oxygen, Photodynamic therapy, In vivo imaging, Luminescence, Signal attenuation, Light scattering, Biomedical optics, Laser therapeutics, Roads, Medicine

PROCEEDINGS ARTICLE | February 21, 2017
Proc. SPIE. 10047, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI
KEYWORDS: Photodynamic therapy, Navigation systems, Infrared imaging, Light, Infrared cameras, Sensors, Light sources, Cameras, Imaging systems, Phase modulation

PROCEEDINGS ARTICLE | February 16, 2017
Proc. SPIE. 10047, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI
KEYWORDS: Photodynamic therapy, Oxygen, Blood circulation, Lung, Mesothelioma, Tissue optics, Tissues, Tumors, Sensors, Luminescence

PROCEEDINGS ARTICLE | February 13, 2017
Proc. SPIE. 10047, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI
KEYWORDS: Photodynamic therapy, Oxygen, Tissue optics, Optical properties, Cancer, Oncology, Collimation, Laser therapeutics, Monte Carlo methods, Optical testing, Tumors, Blood circulation, Tissues, Light scattering, Luminescence, In vivo imaging

PROCEEDINGS ARTICLE | February 13, 2017
Proc. SPIE. 10047, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI
KEYWORDS: Oxygen, Photodynamic therapy, Blood circulation, Spectroscopy, Tumors, Tissues, Tissue optics, In vivo imaging, Luminescence, Radiation oncology

SPIE Journal Paper | February 10, 2017
JBO Vol. 22 Issue 02
KEYWORDS: Control systems, Data modeling, Photodynamic therapy, Oxygen, Tumors, Tissue optics, Optical properties, In vivo imaging, Luminescence, Solids

Showing 5 of 18 publications
SIGN IN TO:
  • View contact details

UPDATE YOUR PROFILE
Is this your profile? Update it now.
Don’t have a profile and want one?

Back to Top